ArticleEmerging microbes & infections2022

Obatoclax inhibits SARS-CoV-2 entry by altered endosomal acidification and impaired cathepsin and furin activity in vitro.

Binli Mao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.